Doppelgerz® Active Vitamin-mineral complex for women, effervescent tablets with lemon flavor

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.E.000386.01.17
Date of registration and renewal:31.01.2017
Dosage form: & nbspEffervescent tablets weighing 6.7 g.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes BAD-sources of mineral substances Supplements containing calcium and phosphorus Supplements containing iodine Supplements containing zinc, copper, manganese Supplements containing potassium and magnesium Supplements containing iron
Composition: & nbspIngredients: calcium carbonate, magnesium carbonate, iron gluconate, zinc sulfate, potassium iodide, folic acid, vitamin C, vitamin D3, citric acid, malic acid, sodium bicarbonate, sodium carbonate, potato starch, sodium cyclamate, flavor, sodium saccharin, riboflavin
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, departments of the trade network as a biologically active food additive - an additional source of calcium, magnesium, iron, zinc, iodine, vitamins: B2, C, D3, folic acid.
Suggested Usage: & nbspOne tablet to dissolve in a glass of water, take the women 1 time per day with meals. Duration of admission is 2 months.After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance to the components of the product, pregnancy, breastfeeding, people with thyroid disease must consult a doctor-endocrinologist.
Special instructions:Before use, consult a physician.
Shelf life:3 years.
Storage conditions:Store in a dry place at a temperature of no higher than 25 ° C.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.010296.11.13 of 11/28/2013, the expert opinion of the FBUC of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2 FT / 5119 of 14.11.2013.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp20.02.2017
Instructions
Up